athenahealth (ATHN) to Release Earnings on Monday

athenahealth (NASDAQ:ATHN) will be posting its quarterly earnings results after the market closes on Monday, February 5th. Analysts expect athenahealth to post earnings of $0.63 per share for the quarter.

Shares of athenahealth (ATHN) opened at $131.22 on Monday. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.35. athenahealth has a fifty-two week low of $95.01 and a fifty-two week high of $158.66. The company has a market cap of $5,250.00, a price-to-earnings ratio of 170.42, a price-to-earnings-growth ratio of 2.99 and a beta of 1.58.

A number of analysts have commented on the stock. Leerink Swann set a $155.00 target price on shares of athenahealth and gave the stock a “hold” rating in a report on Thursday, October 19th. BidaskClub raised shares of athenahealth from a “sell” rating to a “hold” rating in a report on Saturday, December 16th. Jefferies Group set a $110.00 target price on shares of athenahealth and gave the stock a “hold” rating in a report on Friday, October 13th. Robert W. Baird lowered their target price on shares of athenahealth from $170.00 to $155.00 and set an “outperform” rating for the company in a report on Sunday, October 22nd. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and set a $145.00 target price on shares of athenahealth in a report on Friday, October 20th. Two investment analysts have rated the stock with a sell rating, seventeen have assigned a hold rating and eight have given a buy rating to the company. The company has an average rating of “Hold” and an average target price of $142.96.

In related news, CEO Jonathan Bush sold 30,000 shares of the business’s stock in a transaction on Tuesday, December 26th. The shares were sold at an average price of $134.80, for a total value of $4,044,000.00. Following the sale, the chief executive officer now directly owns 320,807 shares of the company’s stock, valued at approximately $43,244,783.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Brandon H. Hull sold 800 shares of the business’s stock in a transaction on Monday, November 20th. The shares were sold at an average price of $130.00, for a total transaction of $104,000.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 67,900 shares of company stock worth $9,142,612. Insiders own 3.20% of the company’s stock.

An institutional investor recently raised its position in athenahealth stock. The Manufacturers Life Insurance Company boosted its stake in athenahealth, Inc (NASDAQ:ATHN) by 7.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,179 shares of the health services provider’s stock after acquiring an additional 84 shares during the quarter. The Manufacturers Life Insurance Company ‘s holdings in athenahealth were worth $166,000 as of its most recent SEC filing.

COPYRIGHT VIOLATION WARNING: “athenahealth (ATHN) to Release Earnings on Monday” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/29/athenahealth-athn-to-release-earnings-on-monday.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Earnings History for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply